Acetylsalicylic acid (Tablets) Instructions for Use
ATC Code
N02BA51 (Acetylsalicylic acid in combination with other drugs, excluding psycholeptics)
Active Substances
Ascorbic acid (Rec.INN WHO registered)
Acetylsalicylic acid (Ph.Eur. European Pharmacopoeia)
Clinical-Pharmacological Group
NSAIDs of combined composition
Pharmacotherapeutic Group
Nonsteroidal anti-inflammatory drug (NSAID) + vitamin
Pharmacological Action
A combined medicinal product with antipyretic and analgesic effects.
Acetylsalicylic acid is an NSAID that inhibits the enzymes COX-1 and COX-2, disrupting the metabolism of arachidonic acid, which leads to impaired prostaglandin synthesis. It has a strong analgesic, antipyretic, and anti-inflammatory effect; reduces thromboxane synthesis and inhibits platelet aggregation, lowering the coagulation status of the blood.
Ascorbic acid (vitamin C) is involved in the regulation of redox processes, carbohydrate metabolism, blood clotting, tissue regeneration, and in the synthesis of steroid hormones; increases the body’s resistance to infections, reduces vascular permeability, and reduces the need for vitamins B1, B2, A, E, folic acid, and pantothenic acid. It satisfies the body’s increased need for vitamin C in diseases accompanied by fever.
Indications
Febrile syndrome in infectious and inflammatory diseases; pain syndrome (of various origins) in adults: headache (including that associated with alcohol withdrawal syndrome), migraine, toothache, neuralgia, myalgia, arthralgia, dysmenorrhea.
ICD codes
| ICD-10 code | Indication |
| F10.3 | Withdrawal state |
| G43 | Migraine |
| K08.8 | Other specified disorders of teeth and supporting structures (including toothache) |
| M25.5 | Pain in joint |
| M79.1 | Myalgia |
| M79.2 | Neuralgia and neuritis, unspecified |
| N94.4 | Primary dysmenorrhea |
| N94.5 | Secondary dysmenorrhea |
| R50 | Fever of unknown origin |
| R51 | Headache |
| R52.0 | Acute pain |
| R52.2 | Other chronic pain |
| ICD-11 code | Indication |
| 6C40.4Z | Alcohol withdrawal syndrome, unspecified |
| 8A80.Z | Migraine, unspecified |
| 8A8Z | Headache disorders, unspecified |
| 8E4A.1 | Paraneoplastic or autoimmune diseases of the peripheral or autonomic nervous system |
| DA0A.Z | Diseases of teeth and supporting structures, unspecified |
| FB56 | Specified soft tissue diseases, not elsewhere classified |
| FB56.2 | Myalgia |
| GA34.3 | Dysmenorrhea |
| LA30.5Z | Anomalies of tooth resorption or loss, unspecified |
| ME82 | Pain in joint |
| MG26 | Fever of other or unknown origin |
| MG30.Z | Chronic pain syndrome, unspecified |
| MG31.Z | Acute pain, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally with a full glass of water. Take with food or milk to minimize gastrointestinal irritation.
The average single dose for adults and children over 15 years of age is 330-800 mg of acetylsalicylic acid. Do not exceed a maximum single dose of 1000 mg.
The maximum daily dose must not exceed 4000 mg (4 grams). In severe pain or febrile conditions, under medical supervision, the maximum daily dose may be increased to 8000 mg (8 grams).
Administer 2-4 times per day. Maintain an interval of at least 4 hours between doses. Do not use for more than 5 days as an analgesic or for more than 3 days as an antipyretic unless directed by a physician.
For dysmenorrhea, initiate treatment at the first sign of pain or bleeding. Continue dosing as needed for 2-3 days.
Crush or chew the tablet if swallowing is difficult. Use the lowest effective dose for the shortest duration necessary to control symptoms.
Discontinue use and consult a physician if symptoms persist, worsen, or new symptoms appear. Avoid in children and adolescents under 15 years of age due to the risk of Reye’s syndrome.
Adverse Reactions
From the digestive system: abdominal pain, nausea, vomiting, overt (black stools, bloody vomit) or covert signs of gastrointestinal bleeding, which can lead to iron deficiency anemia, erosive and ulcerative lesions (including with perforation) of the gastrointestinal tract; rarely – impaired liver function (increased liver transaminases).
From the nervous system: dizziness, tinnitus (usually signs of overdose).
From the hematopoietic system: hemorrhagic syndrome, thrombocytopenia.
From the urinary system: when used in high doses – hyperoxaluria and the formation of urinary stones from calcium oxalate, damage to the glomerular apparatus of the kidneys.
Allergic reactions: skin rash, anaphylactic reactions, bronchospasm, angioedema.
Contraindications
Hypersensitivity to the components of the drug; erosive and ulcerative lesions of the gastrointestinal tract (in the acute phase); gastrointestinal bleeding; bronchial asthma, urticaria or acute rhinitis induced by the intake of acetylsalicylic acid or other NSAIDs; hemophilia; hemorrhagic diathesis; hypoprothrombinemia; portal hypertension; vitamin K deficiency; renal failure; the first and third trimesters of pregnancy; the period of lactation (breastfeeding); glucose-6-phosphate dehydrogenase deficiency; childhood (under 15 years of age – risk of Reye’s syndrome in children with hyperthermia due to viral diseases).
With caution
Gout, liver diseases.
Use in Pregnancy and Lactation
Contraindicated for use in the first and third trimesters of pregnancy and during the lactation period (breastfeeding).
Use in Hepatic Impairment
With caution: liver diseases.
Use in Renal Impairment
Contraindicated in renal failure.
Pediatric Use
Contraindicated for use in children under 15 years of age (risk of Reye’s syndrome in children with hyperthermia due to viral diseases).
Special Precautions
Children should not be prescribed medicines containing acetylsalicylic acid, as in the case of a viral infection they can increase the risk of Reye’s syndrome. Symptoms of Reye’s syndrome are prolonged vomiting, acute encephalopathy, and liver enlargement.
With prolonged use of the drug, monitoring of peripheral blood and the functional state of the liver is necessary.
Since Acetylsalicylic acid slows down blood clotting, a patient who is to undergo surgery should inform the doctor in advance about taking the drug.
Patients with hypersensitivity or asthmoid reactions to salicylates or their derivatives acetylsalicylic acid can be prescribed only with special precautions (in an emergency care setting).
Acetylsalicylic acid in low doses reduces the excretion of uric acid. In patients with a corresponding predisposition, this can in some cases provoke a gout attack.
During treatment, one should refrain from consuming ethanol (increased risk of gastrointestinal bleeding).
Drug Interactions
It enhances the effect of heparin, oral anticoagulants, reserpine, steroid hormones, and hypoglycemic drugs.
Concomitant use of NSAIDs and methotrexate increases the risk of side effects.
It reduces the effectiveness of spironolactone, furosemide, antihypertensive drugs, as well as anti-gout drugs that promote the excretion of uric acid.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Tablets 500 mg+25 mg: 10 or 20 pcs.
Marketing Authorization Holder
Obnovlenie Pfc, JSC (Russia)
Dosage Form
| Acetylsalicylic acid + Ascorbic acid | Tablets 500 mg+25 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or almost white, round, flat-cylindrical, with a bevel and a score; marbling is allowed.
| 1 tab. | |
| Acetylsalicylic acid | 500 mg |
| Ascorbic acid | 25 mg |
Excipients: microcrystalline cellulose 101, corn starch, citric acid monohydrate.
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
Tablets 500 mg+25 mg: 10 or 20 pcs.
Marketing Authorization Holder
Obnovlenie Pfc, JSC (Russia)
Dosage Form
| Acetylsalicylic acid plus Renewal | Tablets 500 mg+25 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
Tablets white or almost white, round, flat-cylindrical, with a bevel and a score; marbling is allowed.
| 1 tab. | |
| Acetylsalicylic acid | 500 mg |
| Ascorbic acid | 25 mg |
Excipients: microcrystalline cellulose 101, corn starch, citric acid monohydrate.
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
